Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner

Experimental and Molecular Pathology

Volumn 84, Issue 3, 2008, Pages 230-233

  Watson, Jane L ^a   Hill, Richard ^a   Lee, Patrick W ^a   Giacomantonio, Carman A ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; Colon cancer; Curcumin; p21; Phytochemical

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; CURCUMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN P21;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL LEVEL; CELL LYSATE; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DEGRADATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CURCUMIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HCT116 CELLS; HUMANS;

CURCUMA LONGA;

EID: 45849140110     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.02.002     Document Type: Article

References (40)

1. Aggarwal B.B., Banerjee S., Bharadwaj U., Sung B., Shishodia S., and Sethi G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem. Pharmacol. 73 (2007) 1024-1032
2. 2 arrest after DNA damage. Science 282 (1998) 1497-1501
3. Bunz F., Hwang P.M., Torrance C., Waldman T., Zhang Y., Dillehay L., Williams J., Lengauer C., Kinzler K.W., and Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104 (1999) 263-269
4. Chang W.T., Kang J.J., Lee K.Y., Wei K., Anderson E., Gotmare S., Ross J.A., and Rosen G.D. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J. Biol. Chem. 276 (2001) 2221-2227
5. Chattopadhyay I., Kaushik B., Bandyopadhyay U., and Banerjee1 R.K. Turmeric and curcumin: biological actions and medicinal applications. Curr. Sci. 87 (2004) 44-54
6. Chen H.W., and Huang H.C. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Brit. J. Pharmacol. 124 (1998) 1029-1040
7. Chen A., Xu J., and Johnson A.C. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor through reducing the activity of the transcription factor Egr-1. Oncogene 25 (2006) 278-287
8. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., and Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001) 2895-2900
9. 2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280 (2005) 20059-20068
10. Gartel A.L., and Tyner A.L. The role of cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 1 (2002) 639-649
11. Harper J.W., Adami G.R., Wei N., Keyomarsi K., and Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 (1993) 805-816
12. -/-HCT116 colon cancer cells. DNA Repair (Amst) 7 (2008) 239-252
13. WAF1/CIP1 and C/EBPβ expressions and suppressing NF-kB activation. Prostate 51 (2002) 211-218
14. Huang M.T., Lou Y.R., Xie J.G., Ma W., Lu Y.P., Yen P., Zhu B.T., Newmark H., and Ho C.T. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 19 (1998) 1697-1700
15. Jaiswal A.S., Marlow B.P., Gupta N., and Narayan S. β-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21 (2002) 8414-8427
16. Jee S.H., Shen S.C., Tseng C.R., Chui H.C., and Kuo M.L. Curcumin induces a p53-dependent apoptosis in human basal carcinoma cells. J. Invest. Dermatol. 111 (1998) 656-661
17. Jemal A., Siegal R., Ward E., Murray T., Xu J., and Thun M. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
18. Waf1/Cip1/Sdi1 and bax. Mol. Carcinog. 21 (1999) 44-52
19. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., and Poirer G.G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53 (1993) 3976-3985
20. Kuttan R., Bhanumathy P., Nirmala K., and George M.C. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 29 (1985) 197-202
21. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandh C., and Chou H.S. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11 (1997) 847-862
22. Li L., Ahmed B., Mehta K., and Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol. Cancer Ther. 6 (2007) 1276-1282
23. cip1/waf1 cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett. 161 (2000) 17-26
24. WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy. Drug Resist. Updat. 6 (2003) 183-195
25. Maddika S., Rao Ande S., Soumya P., Paranjothy T., Weglarczyk K., Zuse A., Eshraghi M., Manda K., Wiechec E., and Los M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updat. 10 (2007) 13-29
26. Mahyar-Roemer M., and Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20 (2001) 3387-3398
27. Mahmoud N.N., Carothers A.M., Grunberger D., Bilinski R.T., Churchill M.R., Martucci C., Newmark H.L., and Bertagnolli M.M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21 (2000) 921-927
28. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
29. KIP1 and p53. Int. J. Oncol. 21 (2002) 379-383
30. Poole A.J., Heap D., Carroll R.E., and Tyner A.L. Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene 23 (2004) 8128-8134
31. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M., Pirmohamed M., Gescher A.J., and Steward W.P. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 10 (2004) 6847-6854
32. Sharma R.A., Gescher A.J., and Steward W.P. Curcumin: the story so far. Eur. J. Cancer 41 (2005) 1955-1968
33. Shishodia S., Chaturvedi M., and Aggarwal B. Role of curcumin in cancer therapy. Curr. Probl. Cancer 31 (2007) 243-305
34. 2+and the activation of caspase-3. Anticancer Res. 26 (2006) 4379-4389
35. Syng-ai C., Kumari A.L., and Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol. Cancer Ther. 3 (2004) 1101-1108
36. Ushida J., Sugie S., Kawabata K., Pham Q.V., Tanaka T., Fujii K., Takeuchi H., Ito Y., and Mori H. Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn. J. Cancer Res. 91 (2000) 893-898
37. Wils J. Adjuvant treatment of colon cancer: past, present and future. J. Chemother. 19 (2007) 115-122
38. Wolf B.B., and Green D.R. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J. Biol. Chem. 274 (1999) 20049-20052
39. Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 18 (1999) 1131-1138
40. 2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res. 14 (2004) 165-171